ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY

This adverse event was reported 637 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY:

# Drug Count
0 ADALIMUMAB 533
1 METHOTREXATE SODIUM 513
2 TOCILIZUMAB 506
3 DICLOFENAC SODIUM 502
4 DICLOFENAC 499
5 METHOTREXATE 496
6 FOLIC ACID 489
7 ETANERCEPT 488
8 DESOXIMETASONE 487
9 ADALIMUMAB-ADAZ 481
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRICLOSAN 84 0.1739
1 TRIPROLIDINE HYDROCHLORIDE 17 0.1000
2 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 48 0.0821
3 BACITRACIN AND POLYMYXIN B SULFATE 1 0.0769
4 CLEAR MINT, GEL TOOTHPASTE 71 0.0700
5 SODIUM FLUORIDE F18 71 0.0695
6 SODIUM FLUORIDE F-18 71 0.0693
7 CAFFEINE CITRATE 139 0.0650
8 DICLOFENAC POTASSIUM TABLETS 366 0.0477
9 BACITRACIN ZINC AND POLYMYXIN B SULFATE 4 0.0392
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY